We are live on ! Find out more
DBTX

Decibel Therapeutics, Inc. Common Stock

Delisted

DBTX was delisted on the 22nd of September, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
O
1
OrbiMed
New York
$17.1M
TGI
2
TRV GP III
Massachusetts
$10.9M
BlackRock
3
BlackRock
New York
$6.53M -$34.8K -7,641 -0.4%
Citadel Advisors
4
Citadel Advisors
Florida
$6.26M +$75.9K +16,678 +0.9%
AI
5
Alphabet Inc
California
$5.66M
SB
6
Samsara BioCapital
California
$2.77M
Vanguard Group
7
Vanguard Group
Pennsylvania
$2.15M
Bessemer Group
8
Bessemer Group
New Jersey
$1.71M
HMC
9
Harvard Management Company
Massachusetts
$1.14M
Millennium Management
10
Millennium Management
New York
$1.1M +$240K +52,720 +20%
NM
11
Newtyn Management
New York
$1.04M -$45.5K -10,000 -3%
Barclays
12
Barclays
United Kingdom
$829K
EI
13
EAM Investors
California
$820K -$82K -18,015 -7%
ECM
14
ExodusPoint Capital Management
New York
$737K -$54.1K -11,893 -5%
BCM
15
Bronte Capital Management
Australia
$566K
UOC
16
UBS O'Connor
Illinois
$546K +$319K +70,000 +80%
JP Morgan Chase
17
JP Morgan Chase
New York
$492K -$27.1K -5,965 -4%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$385K +$185K +40,594 +57%
Neuberger Berman Group
19
Neuberger Berman Group
New York
$237K -$1.82K -400 -0.6%
BCM
20
Bridgeway Capital Management
Texas
$214K -$228K -50,000 -45%
Dimensional Fund Advisors
21
Dimensional Fund Advisors
Texas
$143K +$188K +41,341 New
Renaissance Technologies
22
Renaissance Technologies
New York
$112K +$21.4K +4,700 +17%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$95K +$1.92K +422 +2%
ACA
24
Atlas Capital Advisors
Wyoming
$86.5K
Federated Hermes
25
Federated Hermes
Pennsylvania
$69K